Polyrizon

Polyrizon Retained Earnings

The Retained Earnings of Polyrizon (PLRZ) as of Oct 22, 2026 is -8.40 M USD. In the previous year, Retained Earnings was -5.07 M USD — a change of 65.83% (lower).

Retained Earnings

-8.40 MUSD

YoY

65.83%

Last updated:

Retained Earnings of Polyrizon is 2025 -8.40 M USD. Retained Earnings of Polyrizon was 2024 -5.07 M USD. It decreases by 65.83% lower compared to the previous year.

The Polyrizon Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2020
-1.43 M USD
Jan 1, 2021
-2.14 M USD
Jan 1, 2022
-2.92 M USD
Jan 1, 2023
-3.52 M USD
Jan 1, 2024
-5.07 M USD
Jan 1, 2025
-8.40 M USD
The Polyrizon Retained Earnings history
YEARRetained EarningsYoY
-8.40 MUSD+65.83%
-5.07 MUSD+43.88%
-3.52 MUSD+20.54%
-2.92 MUSD+36.37%
-2.14 MUSD+49.69%
-1.43 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Polyrizon Stock analysis

What does Polyrizon do? Polyrizon Ltd develops medical device hydrogels delivered as nasal sprays that form a thin barrier in the nasal cavity to block viruses and allergens. The company specializes in creating a biological mask using naturally occurring building blocks, focusing on both product development and commercialization. Medical specialists and researchers collaborate with Polyrizon Ltd to advance their intranasal solutions. The firm's primary revenue comes from the development and commercialization of its nasal spray hydrogel products. These products target healthcare providers and consumers seeking protection against viral and allergen exposure. By forming a shield containment barrier, Polyrizon Ltd offers a solution that complements existing health measures without requiring additional equipment. Polyrizon Ltd's business model centers on the creation of a unique nasal barrier technology. The company leverages its focus on intranasal delivery to address market needs for non-invasive protection. Its collaboration with medical specialists ensures that its products meet clinical standards and user requirements. Polyrizon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Polyrizon stock

Retained Earnings of Polyrizon is -8.40 M USD in 2025.

Retained Earnings of Polyrizon changed from -5.07 M USD to -8.40 M USD, representing a 65.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Polyrizon since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Polyrizon historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Polyrizon

All Key Metrics — Polyrizon